RecruitingNot ApplicableNCT05225428

Video Education With Result Dependent dIsclosure

Sponsor

Dana-Farber Cancer Institute

Enrollment

1,020 participants

Start Date

Aug 4, 2022

Study Type

INTERVENTIONAL

Conditions

Breast Cancer Pancreatic Cancer Ovarian Cancer Prostate Cancer Genetic Testing

Summary

The overall study objective of this trial study is to identify and evaluate strategies to improve the accessibility of the video education with result dependent disclosure (VERDI) model, increasingly utilized as a pre-genetic testing (pretest) education alternative in clinical practice, to better serve a more diverse patient population at risk for hereditary cancers.

Eligibility

Min Age: 18 Years

Inclusion Criteria5

Age ≥ 18 years
Current or prior diagnosis of breast cancer, ovarian cancer, pancreatic cancer, prostate cancer, colorectal cancer, renal cancer, melanoma, or sarcoma
Ability to understand spoken or written English or Spanish in a healthcare context
Ability to understand and the willingness to sign a written informed consent document
Black or Latinx (qualitative assessment study only)

Exclusion Criteria5

Prior cancer genetic testing
Prior germline genetic testing
Active hematologic malignancy (e.g. chronic lymphocytic leukemia)
Currently pregnant
Currently incarcerated

Interventions

BEHAVIORALVideo Education

Investigator-developed, professionally animated and produced 8-minute video (Video Education) summarizing the core educational components of a genetic counseling visit

BEHAVIORALGenetic Counseling

Standard genetic counseling